Related Experiment Video
Updated: Aug 6, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Ligand Drift Rate Descriptor in Receptor Pocket: Molecular Docking Sampling for Differentiating Partial Agonists in
Ying-Ting Lin1,2, Yung-Ting Shih1
1Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung807, Taiwan.
None:
The recent discovery that inverse agonists bind to a secondary orthosteric site in PPARγ reveals unexpected structural complexity in this nuclear receptor. To differentiate between full and partial agonists, we hypothesize that partial agonists exhibit dynamic positional behavior, moving among alternative binding sites at equilibrium when saturated, while full agonists bind directly and consistently to the primary orthosteric site. Using a two-state model derived from the Boltzmann distribution and molecular docking (MODO) sampling, we developed a computational metric called the Ligand Drift Rate (LDR) Descriptor to differentiate full agonists (Emax ≥ 90%) from partial agonists (Emax ≤ 45%) of PPARγ by simulating ligand positional instability within the primary orthosteric binding pocket. We combined molecular docking and hydrogen bond fluctuation analysis across 28 PPARγ-ligand complexes (18 full agonists and 10 partial agonists). MODO sampling was performed with several algorithms, each tested on five carefully selected receptor-binding pockets from 356 crystal complexes. Hydrogen bonds between ligands and key residues (His323, His449, Tyr473) were analyzed at various hydrogen-bond displacement (HBD) thresholds (6-12 Å). The LDR was calculated as the percentage of the top 20-scoring poses that lacked hydrogen bonds. We found that adding constraints on pose diversity and allowing receptor flexibility can improve LDR's ability to distinguish full from partial agonists. Finally, MODO-sampling-based LDR calculations were conducted on 1079 ChEMBL ligands (393 full agonists and 686 partial agonists). In this validation set, LDR successfully differentiated partial from full agonists (t-test, p = 0.00043) using the genetic algorithm with the 3B1M-KRC binding pocket and a 10 Å hydrogen-bond threshold. In QSAR applications for drug discovery, we have developed a dynamics-aware molecular descriptor, LDR, that can be a key factor in quantifying partial agonism arising from small-molecule ligand drift away from the primary orthosteric site.
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
The Equilibrium Binding Constant and Binding Strength
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...